Anda belum login :: 07 Jul 2022 04:50 WIB
Detail
ArtikelGenta Sued Over NDA Withdrawal  
Oleh: Mack, George S.
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 22 no. 7 (Jul. 2004), page 788.
Topik: withdrawal; genta sued NDA withdrawal
Ketersediaan
  • Perpustakaan Pusat (Semanggi)
    • Nomor Panggil: NN9.1
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelOn May 4, a dark cloud began dumping torrents of class action lawsuits on the new jersey, based bio pharmaceutical firm Genta for allegedly suppressing amterial information regarding both the toxicity and efefctiveness of its antisense drug Genasense for metastatic malignant melanoma. Genta withdrew its new drug application (NDA) for the product on May 13, ten days after the US food and drug administration's (FDA) Oncologic Drug Advisory Committee (ODAC) declined to recommend approval by a vote of 13 - 3.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.03125 second(s)